Clinical trials in La Louviere – page 91

1 401 clinical trials in La Louviere, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

La Louviere at a glance

1 401

clinical trials

Research sites1

Quick filters

1 401 trials in La Louviere

Open in trial search

Plasma cell myeloma

Not recruiting

Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Registered drugNo placebo

Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Elranatamab
Sponsor:Pfizer Inc.

Contact Research Centre

Fungal infection

Not recruiting

Study on Posaconazole for Treating Fungal Infections in Children Under 2 Years

Registered drugNo placebo

Study on Posaconazole for Treating Fungal Infections in Children Under 2 Years

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Posaconazole
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Malignant peritoneal neoplasm+3

Not recruiting

Study of Farletuzumab Ecteribulin vs. Chemotherapy for Women with Platinum-resistant High-grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Registered drugNo placebo

Study of Farletuzumab Ecteribulin vs. Chemotherapy for Women with Platinum-resistant High-grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Paclitaxel
Sponsor:Bristol Myers Squibb International Corporation

Contact Research Centre

Cervix carcinoma

Not recruiting

Study on Tisotumab Vedotin, Bevacizumab, Carboplatin, and Pembrolizumab for Patients with Recurrent or Stage IVB Cervical Cancer

Registered drugNo placebo

Study on Tisotumab Vedotin, Bevacizumab, Carboplatin, and Pembrolizumab for Patients with Recurrent or Stage IVB Cervical Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Bevacizumab
Sponsor:Genmab A/S

Contact Research Centre

Chronic kidney disease

Not recruiting

Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

Investigational

Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Finerenone
Sponsor:Bayer AG

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Study of Sotorasib Alone and Combined with Pembrolizumab in Adult Patients with Advanced Solid Tumors Having KRAS p.

Registered drugNo placebo

Study of Sotorasib Alone and Combined with Pembrolizumab in Adult Patients with Advanced Solid Tumors Having KRAS p.

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Sotorasib
Sponsor:Amgen Inc.

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Study of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)

Registered drugNo placebo

Study of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Durvalumab
Sponsor:AstraZeneca AB

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Nerandomilast
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Infection in an immunocompromised host

Not recruiting

Study on Maribavir for Treating Cytomegalovirus in Children and Adolescents Post-Transplant

Registered drugNo placebo

Study on Maribavir for Treating Cytomegalovirus in Children and Adolescents Post-Transplant

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Maribavir
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Breast cancer+2

Not recruiting

Study of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer

Registered drug

Study of Tucatinib, Trastuzumab, and Pertuzumab for Patients with Advanced or Metastatic HER2+ Breast Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Pertuzumab
Sponsor:Seagen Inc.

Contact Research Centre

Hormone-refractory prostate cancer

Not recruiting

Study of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

Study of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Enzalutamide
Sponsor:Essa Pharma Inc.

Contact Research Centre

Multiple sclerosis

Not recruiting

Study on the Effects of SAR443820 and Gadobutrol in Patients with Multiple Sclerosis

Registered drug

Study on the Effects of SAR443820 and Gadobutrol in Patients with Multiple Sclerosis

Registered drug

Belgium

Participants:18–64 years
Substances:Gadobutrol
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in La Louviere

What the registry says about research in the country

01 Hematologic Oncology

Innovative research focusing on lymphomas and blood cancers, including studies evaluating novel therapies for diffuse large B-cell lymphoma and multiple myeloma. Clinical trials are investigating combination treatments and maintenance therapies to improve patient outcomes.

DLBCL Treatment Studies
Multiple Myeloma Therapies
Chronic Lymphocytic Leukemia

02 Solid Tumors

Comprehensive research into various solid cancers, with emphasis on non-small cell lung cancer, breast cancer, and colorectal cancer. Studies are exploring targeted therapies and immunotherapy approaches for better treatment outcomes.

Prostate Cancer Treatments
Triple-Negative Breast Cancer
Advanced Lung Cancer Therapies

03 Chronic Conditions

Studies addressing long-term health conditions, including severe asthma and hepatitis B. Research focuses on treatment optimization and understanding patient responses to various therapeutic approaches.

Asthma Management
Hepatitis Treatment
Cardiovascular Disease Prevention

Back to Belgium All countries